Literature DB >> 18397603

Local expression of mIgf-1 modulates ubiquitin, caspase and CDK5 expression in skeletal muscle of an ALS mouse model.

Gabriella Dobrowolny1, Michela Aucello, Mario Molinaro, Antonio Musarò.   

Abstract

OBJECTIVE: The functional connection between muscle and nerve is often altered in several neuromuscular diseases, including amyotrophic lateral sclerosis (ALS). Knowledge about the molecular and cellular mechanisms involved in the restorative reactions is important to our understanding of the processes involved in neuromuscular maintenance. We previously reported that muscle-restricted expression of a localized Igf-1 isoform maintained muscle integrity, stabilized neuromuscular junctions, reduced inflammation in the spinal cord and enhanced motor neuronal survival in SOD(G93A) mice, delaying the onset and progression of the disease. In this study, we analysed potential molecular pathways that are modulated by mIgf-1 to counteract muscle wasting and to preserve motor neurons activity.
METHODS: We performed molecular and morphologic analysis to address the specific proposed questions. RESULTS AND DISCUSSION: Ubiquitin expression and caspase activity resulted markedly increased in SOD(G93A) muscle but maintained at very low levels in the SOD(G93A) x MLC/mIgf-1 (SOD(G93A)/mIgf-1) transgenic muscle. In addition, CDK5 expression, a serine-threonine protein kinase that has been implicated in a number of physiologic processes in nerve and muscle cells, was reduced in SOD(G93A) muscle but increased in SOD(G93A)/mIgf-1 muscle. Notably, while the toxic p25 protein accumulated in SOD(G93A) muscle, no accumulation was evident in the SOD(G93A)/mIgf-1 muscle. The maintenance of muscle phenotype was also associated with maintenance of a normal peripheral nerve, and a greater number of myelinated axons.
CONCLUSION: These observations offer novel insights into the role of mIgf-1 in the attenuation of muscle wasting in the mouse model of ALS disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18397603     DOI: 10.1179/174313208X281235

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  24 in total

1.  Quantity and activation of myofiber-associated satellite cells in a mouse model of amyotrophic lateral sclerosis.

Authors:  Raquel Manzano; Janne M Toivonen; Ana Cristina Calvo; Sara Oliván; Pilar Zaragoza; Maria Jesús Muñoz; Didier Montarras; Rosario Osta
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

2.  A Novel Iron Chelator-Radical Scavenger Ameliorates Motor Dysfunction and Improves Life Span and Mitochondrial Biogenesis in SOD1G93A ALS Mice.

Authors:  Sagit Golko-Perez; Tamar Amit; Orit Bar-Am; Moussa B H Youdim; Orly Weinreb
Journal:  Neurotox Res       Date:  2016-11-08       Impact factor: 3.911

3.  State of the art and the dark side of amyotrophic lateral sclerosis.

Authors:  Antonio Musarò
Journal:  World J Biol Chem       Date:  2010-05-26

Review 4.  The complex molecular biology of amyotrophic lateral sclerosis (ALS).

Authors:  Rachel L Redler; Nikolay V Dokholyan
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

5.  Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors.

Authors:  Cristina Borselli; Hannah Storrie; Frank Benesch-Lee; Dmitry Shvartsman; Christine Cezar; Jeff W Lichtman; Herman H Vandenburgh; David J Mooney
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

6.  Counteracting muscle wasting in aging and neuromuscular diseases: the critical role of IGF-1.

Authors:  Bianca Maria Scicchitano; Emanuele Rizzuto; Antonio Musarò
Journal:  Aging (Albany NY)       Date:  2009-05-13       Impact factor: 5.682

7.  Mechanical properties of intact single fibres from wild-type and MLC/mIgf-1 transgenic mouse muscle.

Authors:  Barbara Colombini; Giulia Benelli; Marta Nocella; Antonio Musarò; Giovanni Cecchi; M Angela Bagni
Journal:  J Muscle Res Cell Motil       Date:  2009       Impact factor: 2.698

8.  Meta-analysis of Genetic Modifiers Reveals Candidate Dysregulated Pathways in Amyotrophic Lateral Sclerosis.

Authors:  Katherine S Yanagi; Zhijin Wu; Joshua Amaya; Natalie Chapkis; Amanda M Duffy; Kaitlyn H Hajdarovic; Aaron Held; Arjun D Mathur; Kathryn Russo; Veronica H Ryan; Beatrice L Steinert; Joshua P Whitt; Justin R Fallon; Nicolas L Fawzi; Diane Lipscombe; Robert A Reenan; Kristi A Wharton; Anne C Hart
Journal:  Neuroscience       Date:  2019-01-01       Impact factor: 3.590

9.  Impaired expression of insulin-like growth factor-1 system in skeletal muscle of amyotrophic lateral sclerosis patients.

Authors:  Christian Lunetta; Massimo Serafini; Alessandro Prelle; Paolo Magni; Elena Dozio; Massimiliano Ruscica; Jenny Sassone; Clarissa Colciago; Maurizio Moggio; Massimo Corbo; Vincenzo Silani
Journal:  Muscle Nerve       Date:  2012-02       Impact factor: 3.217

10.  Muscle atrophy induced by SOD1G93A expression does not involve the activation of caspase in the absence of denervation.

Authors:  Gabriella Dobrowolny; Michela Aucello; Antonio Musarò
Journal:  Skelet Muscle       Date:  2011-01-24       Impact factor: 4.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.